Krystal Biotech Inc (KRYS)
Receivables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 293,354 | 247,796 | 172,511 | 103,808 | 58,154 | 10,946 | 2,390 | 809 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 542 |
| Receivables | US$ in thousands | 104,700 | 97,298 | 103,236 | 46,467 | 42,040 | 9,316 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Receivables turnover | 2.80 | 2.55 | 1.67 | 2.23 | 1.38 | 1.17 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $293,354K ÷ $104,700K
= 2.80
The receivables turnover ratio for Krystal Biotech Inc has shown significant improvement over the last few quarters, starting from 1.17 in September 30, 2023, increasing to 2.80 by December 31, 2024. This indicates that the company is managing its accounts receivable more efficiently and collecting outstanding payments at a faster pace. A higher receivables turnover ratio generally signifies better liquidity, as it implies that the company is able to convert its receivables into cash quickly. This improved efficiency in receivables management could potentially lead to better cash flow and working capital management for Krystal Biotech Inc.
Peer comparison
Dec 31, 2024